BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee SH, McCormick F. Downregulation of Skp2 and p27/Kip1 synergistically induces apoptosis in T98G glioblastoma cells. J Mol Med (Berl) 2005;83:296-307. [PMID: 15605273 DOI: 10.1007/s00109-004-0611-7] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Radons J. The role of inflammation in sarcoma. Adv Exp Med Biol 2014;816:259-313. [PMID: 24818727 DOI: 10.1007/978-3-0348-0837-8_11] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
2 Bassermann F, Eichner R, Pagano M. The ubiquitin proteasome system - implications for cell cycle control and the targeted treatment of cancer. Biochim Biophys Acta 2014;1843:150-62. [PMID: 23466868 DOI: 10.1016/j.bbamcr.2013.02.028] [Cited by in Crossref: 142] [Cited by in F6Publishing: 141] [Article Influence: 17.8] [Reference Citation Analysis]
3 Sabit H, Tombuloglu H, Cevik E, Abdel-Ghany S, El-Zawahri E, El-Sawy A, Isik S, Al-Suhaimi E. Knockdown of c-MYC Controls the Proliferation of Oral Squamous Cell Carcinoma Cells in vitro via Dynamic Regulation of Key Apoptotic Marker Genes. Int J Mol Cell Med 2021;10:45-55. [PMID: 34268253 DOI: 10.22088/IJMCM.BUMS.10.1.45] [Reference Citation Analysis]
4 Berton S, Belletti B, Wolf K, Canzonieri V, Lovat F, Vecchione A, Colombatti A, Friedl P, Baldassarre G. The tumor suppressor functions of p27(kip1) include control of the mesenchymal/amoeboid transition. Mol Cell Biol 2009;29:5031-45. [PMID: 19596789 DOI: 10.1128/MCB.00144-09] [Cited by in Crossref: 51] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
5 Yu WN, Nogueira V, Sobhakumari A, Patra KC, Bhaskar PT, Hay N. Systemic Akt1 Deletion after Tumor Onset in p53(-/-) Mice Increases Lifespan and Regresses Thymic Lymphoma Emulating p53 Restoration. Cell Rep 2015;12:610-21. [PMID: 26190111 DOI: 10.1016/j.celrep.2015.06.057] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
6 Sun Y. E3 ubiquitin ligases as cancer targets and biomarkers. Neoplasia. 2006;8:645-654. [PMID: 16925947 DOI: 10.1593/neo.06376] [Cited by in Crossref: 125] [Cited by in F6Publishing: 131] [Article Influence: 8.3] [Reference Citation Analysis]
7 Wu J, Su HK, Yu ZH, Xi SY, Guo CC, Hu ZY, Qu Y, Cai HP, Zhao YY, Zhao HF, Chen FR, Huang YF, To ST, Feng BH, Sai K, Chen ZP, Wang J. Skp2 modulates proliferation, senescence and tumorigenesis of glioma. Cancer Cell Int 2020;20:71. [PMID: 32165861 DOI: 10.1186/s12935-020-1144-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
8 Das A, Chai JC, Jung KH, Das ND, Kang SC, Lee YS, Seo H, Chai YG. JMJD2A attenuation affects cell cycle and tumourigenic inflammatory gene regulation in lipopolysaccharide stimulated neuroectodermal stem cells. Exp Cell Res 2014;328:361-78. [PMID: 25193078 DOI: 10.1016/j.yexcr.2014.08.029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
9 Galeano F, Rossetti C, Tomaselli S, Cifaldi L, Lezzerini M, Pezzullo M, Boldrini R, Massimi L, Di Rocco CM, Locatelli F. ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis. Oncogene. 2013;32:998-1009. [PMID: 22525274 DOI: 10.1038/onc.2012.125] [Cited by in Crossref: 84] [Cited by in F6Publishing: 81] [Article Influence: 9.3] [Reference Citation Analysis]
10 Yan J, Yao Z, Hu K, Zhong Y, Li M, Xiong Z, Deng M. Hepatitis B Virus Core Promoter A1762T/G1764A (TA)/T1753A/T1768A Mutations Contribute to Hepatocarcinogenesis by Deregulating Skp2 and P53. Dig Dis Sci 2015;60:1315-24. [DOI: 10.1007/s10620-014-3492-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
11 Jung D, Khurana A, Roy D, Kalogera E, Bakkum-Gamez J, Chien J, Shridhar V. Quinacrine upregulates p21/p27 independent of p53 through autophagy-mediated downregulation of p62-Skp2 axis in ovarian cancer. Sci Rep 2018;8:2487. [PMID: 29410485 DOI: 10.1038/s41598-018-20531-w] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 6.7] [Reference Citation Analysis]
12 Huang HC, Way TD, Lin CL, Lin JK. EGCG stabilizes p27kip1 in E2-stimulated MCF-7 cells through down-regulation of the Skp2 protein. Endocrinology 2008;149:5972-83. [PMID: 18719023 DOI: 10.1210/en.2008-0408] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
13 Zhang H, Yi J, Yoon D, Ryoo Z, Lee I, Kim M. Imatinib and GNF-5 Exhibit an Inhibitory Effect on Growth of Hepatocellar Carcinoma Cells by Downregulating S-phase Kinase-associated Protein 2. J Cancer Prev 2020;25:252-7. [PMID: 33409258 DOI: 10.15430/JCP.2020.25.4.252] [Reference Citation Analysis]
14 Chen L, Tweddle DA. p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance. Front Oncol 2012;2:173. [PMID: 23226679 DOI: 10.3389/fonc.2012.00173] [Cited by in Crossref: 19] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
15 Nickeleit I, Zender S, Kossatz U, Malek NP. p27kip1: a target for tumor therapies? Cell Div. 2007;2:13. [PMID: 17488529 DOI: 10.1186/1747-1028-2-13] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
16 Wang C, Li S, Liu J, Cheng M, Wang D, Wang Y, Lu B. Silencing of S-phase kinase-associated protein 2 enhances radiosensitivity of esophageal cancer cells through inhibition of PI3K/AKT signaling pathway. Genomics 2020;112:3504-10. [PMID: 32360515 DOI: 10.1016/j.ygeno.2020.04.029] [Reference Citation Analysis]
17 Saigusa K, Hashimoto N, Tsuda H, Yokoi S, Maruno M, Yoshimine T, Aoyagi M, Ohno K, Imoto I, Inazawa J. Overexpressed Skp2 within 5p amplification detected by array-based comparative genomic hybridization is associated with poor prognosis of glioblastomas. Cancer Sci 2005;96:676-83. [PMID: 16232199 DOI: 10.1111/j.1349-7006.2005.00099.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
18 Mudryj M, Reay E, Beckett L, Dandekar S, deVere White R, Gandour-edwards R. Novel p53/p130 Axis in Bladder Tumors. Urology 2007;70:608-12. [DOI: 10.1016/j.urology.2007.05.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
19 Kitagawa M, Lee SH, McCormick F. Skp2 suppresses p53-dependent apoptosis by inhibiting p300. Mol Cell 2008;29:217-31. [PMID: 18243116 DOI: 10.1016/j.molcel.2007.11.036] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 5.9] [Reference Citation Analysis]
20 Li W, Li F, Zhu Y, Song D. RETRACTED: Physcion 8-O-β-glucopyranosideregulates cell cycle, apoptosis, and invasion in glioblastoma cells through modulating Skp2. Biomed Pharmacother 2017;95:1129-38. [PMID: 28922732 DOI: 10.1016/j.biopha.2017.09.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
21 Lim C, Ky N, Ng H, Hamza MS, Yan Zhao. Curcuma wenyujin Extract Induces Apoptosis and Inhibits Proliferation of Human Cervical Cancer Cells In Vitro and In Vivo. Integr Cancer Ther 2010;9:36-49. [DOI: 10.1177/1534735409359773] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
22 Zhang Q, Spears E, Boone DN, Li Z, Gregory MA, Hann SR. Domain-specific c-Myc ubiquitylation controls c-Myc transcriptional and apoptotic activity. Proc Natl Acad Sci U S A 2013;110:978-83. [PMID: 23277542 DOI: 10.1073/pnas.1208334110] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
23 Wang L, Ye X, Cai X, Su J, Ma R, Yin X, Zhou X, Li H, Wang Z. Curcumin suppresses cell growth and invasion and induces apoptosis by down-regulation of Skp2 pathway in glioma cells. Oncotarget 2015;6:18027-37. [PMID: 26046466 DOI: 10.18632/oncotarget.4090] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 8.6] [Reference Citation Analysis]
24 Huang J, Zhang F, Jiang L, Hu G, Sun W, Zhang C, Ding X. Inhibition of SKP2 Sensitizes Bromocriptine-Induced Apoptosis in Human Prolactinoma Cells. Cancer Res Treat 2017;49:358-73. [PMID: 27488872 DOI: 10.4143/crt.2016.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
25 Chin YR, Yuan X, Balk SP, Toker A. PTEN-deficient tumors depend on AKT2 for maintenance and survival. Cancer Discov. 2014;4:942-955. [PMID: 24838891 DOI: 10.1158/2159-8290.cd-13-0873] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 7.7] [Reference Citation Analysis]
26 Einama T, Kagata Y, Tsuda H, Morita D, Ogata S, Ueda S, Takigawa T, Kawarabayashi N, Fukatsu K, Sugiura Y, Matsubara O, Hatsuse K. High-level Skp2 expression in pancreatic ductal adenocarcinoma: correlation with the extent of lymph node metastasis, higher histological grade, and poorer patient outcome. Pancreas 2006;32:376-81. [PMID: 16670630 DOI: 10.1097/01.mpa.0000220862.78248.c4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
27 Gupta I, Singh K, Varshney NK, Khan S. Delineating Crosstalk Mechanisms of the Ubiquitin Proteasome System That Regulate Apoptosis. Front Cell Dev Biol 2018;6:11. [PMID: 29479529 DOI: 10.3389/fcell.2018.00011] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 11.7] [Reference Citation Analysis]
28 Jia L, Sun Y. SCF E3 ubiquitin ligases as anticancer targets. Curr Cancer Drug Targets 2011;11:347-56. [PMID: 21247385 DOI: 10.2174/156800911794519734] [Cited by in Crossref: 96] [Cited by in F6Publishing: 87] [Article Influence: 9.6] [Reference Citation Analysis]
29 Jia J, Yan D, Wang Y, Liu M, Jia Z, Luo L, Ren J, Fang J, Yuan H, Zhao Y, Song Y, He Y, Wang X. Skp2 regulates DNA damage repair and apoptosis via interaction with Ku70. Exp Cell Res 2020;397:112335. [PMID: 33132134 DOI: 10.1016/j.yexcr.2020.112335] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Sistrunk C, Kim SH, Wang X, Lee SH, Kim Y, Macias E, Rodriguez-Puebla ML. Skp2 deficiency inhibits chemical skin tumorigenesis independent of p27(Kip1) accumulation. Am J Pathol 2013;182:1854-64. [PMID: 23474082 DOI: 10.1016/j.ajpath.2013.01.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
31 Liu S, Yin F, Fan W, Wang S, Guo XR, Zhang JN, Tian ZM, Fan M. Over-expression of BMPR-IB reduces the malignancy of glioblastoma cells by upregulation of p21 and p27Kip1. J Exp Clin Cancer Res 2012;31:52. [PMID: 22650359 DOI: 10.1186/1756-9966-31-52] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
32 Boyer MJ, Cheng T. The CDK inhibitors: potential targets for therapeutic stem cell manipulations? Gene Ther 2008;15:117-25. [DOI: 10.1038/sj.gt.3303064] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
33 Cheng ZJ, Cai HQ, Zhang MJ, Zhong Y, He J, Yuan Q, Hao JJ, Wang MR, Wan JH. High S phase kinase-associated protein 2 expression is a potential prognostic biomarker for glioma. Oncol Lett 2020;20:2788-96. [PMID: 32782596 DOI: 10.3892/ol.2020.11818] [Reference Citation Analysis]
34 Reed SI. Deathproof: new insights on the role of skp2 in tumorigenesis. Cancer Cell 2008;13:88-9. [PMID: 18242509 DOI: 10.1016/j.ccr.2008.01.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
35 Wang Z, Fukushima H, Inuzuka H, Wan L, Liu P, Gao D, Sarkar FH, Wei W. Skp2 is a promising therapeutic target in breast cancer. Front Oncol 2012;1:18702. [PMID: 22279619 DOI: 10.3389/fonc.2011.00057] [Cited by in Crossref: 37] [Cited by in F6Publishing: 47] [Article Influence: 4.1] [Reference Citation Analysis]
36 Liu H, Yue Q, He S. Amentoflavone suppresses tumor growth in ovarian cancer by modulating Skp2. Life Sciences 2017;189:96-105. [DOI: 10.1016/j.lfs.2017.09.026] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
37 Ouyang J, Xu H, Li M, Dai X, Fu F, Zhang X, Lan Q. Paeoniflorin exerts antitumor effects by inactivating S phase kinase-associated protein 2 in glioma cells. Oncol Rep 2018;39:1052-62. [PMID: 29286139 DOI: 10.3892/or.2017.6175] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
38 Wei Z, Jiang X, Liu F, Qiao H, Zhou B, Zhai B, Zhang L, Zhang X, Han L, Jiang H. Downregulation of Skp2 inhibits the growth and metastasis of gastric cancer cells in vitro and in vivo. Tumour Biol. 2013;34:181-192. [PMID: 23229098 DOI: 10.1007/s13277-012-0527-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]